Holen Sie sich die Stockscreener-App
1.25
3.47%
-0.045
Handel nachbörslich:
1.27
0.02
+1.60%
Schlusskurs vom Vortag:
$1.295
Offen:
$1.32
24-Stunden-Volumen:
39,608
Relative Volume:
0.46
Marktkapitalisierung:
$9.59M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.1504
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
-8.09%
1M Leistung:
-3.10%
6M Leistung:
-56.42%
1J Leistung:
-91.75%
1-Tages-Spanne:
$1.25
$1.32
1-Wochen-Bereich:
$1.25
$1.40
52-Wochen-Spanne:
$1.09
$18.75
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Firmenname
Ernexa Therapeutics Inc
Sektor
Branche
Telefon
(617) 798-6700
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Vergleichen Sie ERNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.25 | 9.93M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
What the charts say about Ernexa Therapeutics Inc. todayMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Should I hold or sell Ernexa Therapeutics Inc. stock in 2025Earnings Growth Report & Verified Technical Signals - newser.com
Smart tools for monitoring Ernexa Therapeutics Inc.’s price action2025 Year in Review & Daily Momentum Trading Reports - newser.com
Why Ernexa Therapeutics Inc. stock could rally in 2025July 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Order flow analysis tools used on Ernexa Therapeutics Inc.2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Ernexa Therapeutics’ (ERNA) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Historical volatility pattern of Ernexa Therapeutics Inc. visualizedJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
How moving averages guide Ernexa Therapeutics Inc. tradingWatch List & Long Hold Capital Preservation Plans - newser.com
Can Ernexa Therapeutics Inc. stock sustain market leadershipJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Custom strategy builders for tracking Ernexa Therapeutics Inc.Portfolio Profit Report & Smart Allocation Stock Tips - newser.com
Ernexa Therapeutics to Deliver Company Presentation At the Annual Cell & Gene Meeting on the Mesa - MarketScreener
Ernexa Therapeutics to Present at Cell & Gene Meeting on the Mesa, Highlighting Advances in iMSC Therapies for Cancer and Autoimmune Disease - Quiver Quantitative
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa - GlobeNewswire
Leading Cancer Cell Therapy: Ernexa Therapeutics to Showcase iMSC Platform at Major Industry Conference - Stock Titan
Ernexa Therapeutics: Interview With President & CEO Sanjeev Luther About The Innovative Cell Therapy Company - Pulse 2.0
Ernexa Therapeutics CEO Sanjeev Luther to Speak at 5th Annual iPSC Drug Development Summit - Quiver Quantitative
Ernexa Therapeutics President & CEO Sanjeev Luther to - GlobeNewswire
Cancer & Autoimmune Cell Therapy Pioneer: Ernexa CEO to Present iMSC Breakthroughs at iPSC Summit - Stock Titan
Ernexa Therapeutics Inc Stock Analysis and ForecastResistance Breakout Alerts & Small Investment Capital Gains - earlytimes.in
Ernexa Therapeutics (NASDAQ:ERNA) versus Savara (NASDAQ:SVRA) Critical Comparison - Defense World
Ernexa Therapeutics Inc. stock volume spike explained2025 Market Overview & Verified High Yield Trade Plans - newser.com
What analysts say about Ernexa Therapeutics Inc stockGrowth vs. Value Investing & Affordable Stock Market Tips - Early Times
Published on: 2025-09-22 07:32:05 - newser.com
Momentum divergence signals in Ernexa Therapeutics Inc. chartJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Fund Flows: Will Ernexa Therapeutics Inc outperform tech stocksJuly 2025 PreEarnings & Risk Controlled Swing Alerts - خودرو بانک
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ernexa Therapeutics Inc-Aktie (ERNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):